PSivida receives first quarterly payment from Pfizer
pSivida has received its first quarterly payment of $500,000 from Pfizer as specified by the terms of an exclusive worldwide collaborative research and license agreement signed by the two companies in April, pSivida announced in a press release.
Pfizer Inc. said yesterday it paid US$35-million to about 4,500 doctors and researchers from July through December 2009 for a variety of services, including speaking fees, expert advice and work on clinical trials of its medicines.